Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models

Doxorubicin (DOX) is an anthracycline widely used in cancer therapy and in particular in breast cancer treatment. The treatment with DOX appears successful, but it is limited by a severe cardiotoxicity. This work evaluated the in vitro and in vivo anticancer effect of a new formulation of β-cyclodex...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Argenziano, Monica, Gigliotti, Casimiro Luca, Clemente, Nausicaa, Boggio, Elena, Ferrara, Benedetta, Trotta, Francesco, Pizzimenti, Stefania, Barrera, Giuseppina, Boldorini, Renzo, Bessone, Federica, Dianzani, Umberto, Cavalli, Roberta, Dianzani, Chiara
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7016577/
https://ncbi.nlm.nih.gov/pubmed/31936526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010162
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky